Simple Summary With estimated numbers of 1–10 per mL of blood, circulating tumor cells
(CTCs) are extremely rare compared to white (a few million) or red (billions) blood cells …

Circulating tumor cells (CTCs) are cancer cells discovered in cancer patients' peripheral
blood that successfully escape from the primary tumor site and/or metastases, struggle to …

Circulating tumor cells (CTCs) could be considered a sign of tumor aggressiveness, but
highly sensitive and specific methods of CTC detection are necessary owing to the rarity and …

Circulating tumor cells (CTCs) are cells that shed from a primary tumor and travel through
the bloodstream. Studying the functional and molecular characteristics of CTCs may provide …

The detection and enumeration of circulating tumor cells (CTCs) has shown significant
clinical utility with respect to prognosis in breast, colorectal and prostate cancers. Emerging …

Eight million people die of cancer each year and 90% of deaths are caused by systemic
disease. Circulating tumor cells (CTCs) contribute to the formation of metastases and thus …

The presence of circulating tumor cells (CTCs) accompanies tumor invasion into the
bloodstream. Detection, monitoring, and molecular analysis of these rare cancer cells shed …

Circulating tumor cells (CTCs) play a central role in tumor dissemination and metastases,
which are ultimately responsible for most cancer deaths. Technologies that allow for …

Disseminated malignancy is responsible for the vast majority of cancer-related deaths.
During this process, circulating tumor cells (CTC) are generated, spread from the primary …

Abstract Purpose of Review Circulating tumor cells represent rare events in the peripheral
blood of patients with cancer that can provide insight into tumor biology. CTC enumeration …